These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18301786)

  • 1. Erythropoietin treatment for ischemic cardiomyopathy: anemia correction and myocardial protection.
    Ben-Dor I; Battler A
    Timely Top Med Cardiovasc Dis; 2007 Dec; 11():E33. PubMed ID: 18301786
    [No Abstract]   [Full Text] [Related]  

  • 2. [Erythropoietin in the treatment of heart failure and ischemia].
    Lewartowski B
    Kardiol Pol; 2007 Feb; 65(2):192-7. PubMed ID: 17366366
    [No Abstract]   [Full Text] [Related]  

  • 3. Erythropoietin in heart failure.
    Silverberg DS; Wexler D; Blum M; Iaina A; Sheps D; Keren G; Schwartz D
    Semin Nephrol; 2005 Nov; 25(6):397-403. PubMed ID: 16298262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Erythropoietin as a protective agent in myocardial ischemia].
    Schwartzenberg S; Keren G; George J
    Harefuah; 2006 May; 145(5):380-3, 396. PubMed ID: 16805223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoiesis-stimulating agents: favorable safety profile when used as indicated.
    Nowrousian MR; Dunst J; Vaupel P
    Strahlenther Onkol; 2008 Mar; 184(3):121-36. PubMed ID: 18330508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of beta-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with cardiorenal anemia syndrome.
    Leszek P; Kruszewski M
    Am Heart J; 2008 Mar; 155(3):e25; author reply e19. PubMed ID: 18294469
    [No Abstract]   [Full Text] [Related]  

  • 7. Adverse consequences with use of erythropoiesis-stimulating agents in anemia prompt release of guidelines to ensure safe use and maximize benefit.
    Dharmarajan TS; Widjaja D
    Geriatrics; 2008 Jun; 63(6):13-29. PubMed ID: 18512996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anemia in chronic heart failure: etiology and treatment options.
    Westenbrink BD; de Boer RA; Voors AA; van Gilst WH; van Veldhuisen DJ
    Curr Opin Cardiol; 2008 Mar; 23(2):141-7. PubMed ID: 18303527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correction of anemia in renal insufficiency: what target?].
    Drüeke TB
    Nephrol Ther; 2008 Oct; 4 Spec No 2():1-8. PubMed ID: 19000892
    [No Abstract]   [Full Text] [Related]  

  • 10. A prognostic index relating 24-hour ambulatory blood pressure to cardiac events in ischemic cardiomyopathy following defibrillator implantation.
    Antonini L; Colivicchi F; Pasceri V; Greco S; Varveri A; Turani L; Kol A; Santini M
    Pacing Clin Electrophysiol; 2008 Sep; 31(9):1089-94. PubMed ID: 18834457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic kidney disease, heart failure and anemia.
    Virani SA; Khosla A; Levin A
    Can J Cardiol; 2008 Jul; 24 Suppl B(Suppl B):22B-4B. PubMed ID: 18629385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anemia as complication of chronic heart failure: prevalence, treatment, prognosis].
    Tereshchenko SN; Atroshchenko ES; Uskach TM; Kudinova AA; Riabinina MN
    Ter Arkh; 2008; 80(9):90-5. PubMed ID: 19555048
    [No Abstract]   [Full Text] [Related]  

  • 13. Coenzyme Q(10) and congestive heart failure: what is the verdict?
    Raj SR; Weisel RD; Verma S
    Can J Cardiol; 2002 Oct; 18(10):1054-8. PubMed ID: 12420040
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiovascular effects of erythropoietin: anemia and beyond.
    Guglin ME; Koul D
    Cardiol Rev; 2006; 14(4):200-4. PubMed ID: 16788333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biological similarity of erythropoietin: controlled maturation].
    Combe C
    Nephrol Ther; 2009 Feb; 5 Spec No1():1-2. PubMed ID: 19233074
    [No Abstract]   [Full Text] [Related]  

  • 16. Do erythropoietin receptors on cancer cells explain unexpected clinical findings?
    Clavo B
    J Clin Oncol; 2007 Apr; 25(11):1447-8; author reply 1448. PubMed ID: 17416869
    [No Abstract]   [Full Text] [Related]  

  • 17. Biological approaches to ischemic tissue repair: gene- and cell-based strategies.
    Roncalli J; Tongers J; Renault MA; Losordo DW
    Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):653-68. PubMed ID: 18510483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New applications of erythropoietin in cardiovascular disease: from haematopoiesis to cardiac protection].
    van der Meer P; van Veldhuisen DJ
    Ned Tijdschr Geneeskd; 2008 Apr; 152(16):923-7. PubMed ID: 18561787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing anemia. What do we do now? Views from Canada.
    Mendelssohn DC; Muirhead N; Manns BJ
    Nephrol News Issues; 2007 Jun; 21(7):55-7. PubMed ID: 17623988
    [No Abstract]   [Full Text] [Related]  

  • 20. [Erythropoietin in patients with chronic heart failure].
    Makarova NA; Shaposhnik II; Zakharov IuM
    Klin Med (Mosk); 2009; 87(3):31-4. PubMed ID: 19469252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.